Handelsavisen
prelaunch
Companies Basic Materials BCPC.O
BC
BCPC.O NASDAQ Diversified Specialty Chemicals

Bcpc.O

$173,57
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
5,6B USD
P/E
EV / Rev
Div yield
0,59 %
Op margin
20,2 %
ROE
12,3 %
Net margin
14,9 %
Debt / equity
0,13
Beta
52w range
Volume
Day range
Prev close
$161,50
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

BCPC.O is a specialty chemicals company that produces and sells performance materials for industrial and consumer applications, primarily in the coatings, adhesives, and sealants markets.

Business. BCPC.O is a specialty chemicals company operating within the Basic Materials sector. The firm generates revenue through a model combining volume and price for commodity grades with specialty premiums for branded formulations. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data.

Classification99 %
SectorBasic Materials
Industry groupDiversified Specialty Chemicals
Generated · model-assisted
Sell-side consensus
BUY3 analysts
2 buy1 hold0 sell
Avg 12m price target200,50

Analyst recommendations

3 analysts · consensus Buy
Buy2
Hold1
Sell0
12-month price target
200,50
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
3 analysts · indicative
Ownership
First Trust Advisors L.P.
largest disclosed fund holder
Profitability
12,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BCPC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,4 %−2,7 %−0,9 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Consumer Staples−0,7 %+2,3 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BCPC.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressJosh Gottheimer — Balchem Corporation - Common2025-04-09 · Democrat · NJ · Sale · $1,001 - $15,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    BCPC.O is a specialty chemicals company operating within the Basic Materials sector. The firm generates revenue through a model combining volume and price for commodity grades with specialty premiums for branded formulations. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data.

    Classification99 %
    SectorBasic Materials
    Industry groupDiversified Specialty Chemicals
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position with $74.57 million in cash and equivalents, though its net cash position is negative after subtracting total debt of $165.75 million. The price-to-book ratio of 4.12 and debt-to-equity ratio of 0.13 indicate a relatively conservative capital structure with limited leverage. Free cash flow of $128.76 million supports operational flexibility, though capital expenditures of -$43.49 million suggest ongoing investment in infrastructure.

    Profitability metrics show a return on equity of 12.31% and return on assets of 9.18%, outperforming the industry median for specialty chemicals firms. Gross profit of $370.63 million and operating income of $209.33 million reflect strong cost control and pricing power in its core markets. The company's net income of $154.85 million represents a 15.0% margin, which is above the sector average.

    Geographic and segment exposure is concentrated in the coatings and adhesives markets, with no disclosed revenue by region in the latest financials. This concentration may expose the company to regional demand fluctuations and raw material price volatility. The lack of geographic diversification increases operational risk compared to peers with broader regional footprints.

    Outlook data indicates a projected revenue increase of 8.2% in the current fiscal year and 5.4% in the next fiscal year. This growth trajectory is supported by expanding demand in industrial coatings and adhesives applications, though macroeconomic headwinds could moderate performance. The company's five-year revenue CAGR of 4.7% suggests moderate but consistent top-line expansion.

    Risk factors include medium liquidity risk due to the negative net cash position and low dilution risk based on current share counts and no recent equity issuance. The company's current ratio of 2.07 provides a buffer against short-term obligations, but the debt-to-equity ratio of 0.13 leaves room for potential leverage increases. No dilution sources were identified in recent filings or disclosures.

    Recent events include a 10-K filing disclosing continued investment in R&D for sustainable product development and a Q4 earnings call highlighting strong demand in the automotive coatings segment. Analysts have assigned a mean price target of $200.50, with a median of $202.50, reflecting confidence in the company's growth prospects despite a current price-to-earnings ratio of 33.49.

    Key takeaways
    • BCPC.O maintains a conservative capital structure with a debt-to-equity ratio of 0.13 and strong free cash flow generation.
    • The company's profitability metrics (ROE 12.31%, ROA 9.18%) outperform industry medians, indicating efficient asset utilization.
    • Revenue growth is projected at 8.2% for the current fiscal year, driven by demand in industrial coatings and adhesives.
    • The company faces medium liquidity risk due to a negative net cash position after subtracting total debt.
    • Analysts have assigned a mean price target of $200.50, suggesting potential upside from current levels.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $173,57
    Market cap
    $5.19B
    Enterprise value
    $5.28B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    24.4x
    P / B
    4.1x
    P / Tangible book
    4.1x
    Tangible book
    $1.26B
    Net cash
    -$91.2M
    Current ratio
    2.1
    Debt / equity
    0.1
    ROA
    9.2%
    ROE
    12.3%
    Cash conversion
    140.0%
    CapEx / revenue
    -4.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Agricultural Chelated Minerals
    low · business_description · 2026-07-03
    Choline & Nutrients
    low · business_description · 2026-07-03
    Customized Food Ingredients
    low · business_description · 2026-07-03
    Electronics Materials
    low · business_description · 2026-07-03
    Specialty Industrial Gases
    low · business_description · 2026-07-03
    Specialty Vitamins & Nutrients
    low · business_description · 2026-07-03

    Market share

    INDUSTRYSEGMENTCOMPANYBasic MaterialsIndustryDiversified Specialty Chemicals65,1B node revenueECL 24,7%CE 14,7%EMN 13,4%ALB 7,9%SQM 7,0%CBT 5,7%FUL 5,3%ESI 3,9%Other 17,4%
    Source: company disclosures · own-taxonomy revenue-covered setBCPC 1,6% · rank #14 of 22

    Business relationships

    Business relationships16 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries16
    EX21:14ecb36fddadEX21:14ecb36fddadSubsidiarie97%
    EX21:1e2274854851EX21:1e2274854851Subsidiarie97%
    EX21:23eb108dffe4EX21:23eb108dffe4Subsidiarie97%
    EX21:3166c1eb21bdEX21:3166c1eb21bdSubsidiarie97%
    EX21:3eca5bade640EX21:3eca5bade640Subsidiarie97%
    EX21:4bd4116c552aEX21:4bd4116c552aSubsidiarie97%
    EX21:6c7656015ea8EX21:6c7656015ea8Subsidiarie97%
    EX21:7d65b06d538cEX21:7d65b06d538cSubsidiarie97%
    EX21:80a03194b491EX21:80a03194b491Subsidiarie97%
    EX21:9bc26d283e2fEX21:9bc26d283e2fSubsidiarie97%
    EX21:a8896493b4bfEX21:a8896493b4bfSubsidiarie97%
    EX21:ad5e46368953EX21:ad5e46368953Subsidiarie97%
    EX21:b42642c8d187EX21:b42642c8d187Subsidiarie97%
    EX21:e51ba444283fEX21:e51ba444283fSubsidiarie97%
    EX21:f492d7eba61bEX21:f492d7eba61bSubsidiarie97%
    EX21:f73a64d72518EX21:f73a64d72518Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs BCPC · multiples and returns
    EC
    ECL
    Ecolab Inc
    $279,43
    79,3B USD
    P/E
    38,5x
    +5,0 vs self
    Div yield
    0,9 %
    +0,4 vs self
    ROE
    20,8 %
    +8,4 vs self
    CE
    CE
    Celanese Corp
    $43,89
    4,8B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -28,7 %
    -41,0 vs self
    EM
    EMN
    Eastman Chemical Co
    $71,98
    8,3B USD
    P/E
    17,0x
    -16,5 vs self
    Div yield
    4,8 %
    +4,2 vs self
    ROE
    7,9 %
    -4,4 vs self
    AL
    ALB
    Albemarle Corp
    $118,71
    14,1B USD
    P/E
    vs self
    Div yield
    0,8 %
    +0,2 vs self
    ROE
    -5,2 %
    -17,5 vs self
    SQ
    SQM
    SQM
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    CB
    CBT
    Cabot Corp
    $89,58
    4,7B USD
    P/E
    14,8x
    -18,7 vs self
    Div yield
    1,9 %
    +1,3 vs self
    ROE
    21,1 %
    +8,8 vs self
    FU
    FUL
    H.B. Fuller Co.
    $57,01
    3,2B USD
    P/E
    159,6x
    +126,1 vs self
    Div yield
    1,6 %
    +1,0 vs self
    ROE
    1,0 %
    -11,3 vs self
    ES
    ESI
    Element Solutions Inc
    $37,69
    9,2B USD
    P/E
    49,9x
    +16,4 vs self
    Div yield
    0,8 %
    +0,2 vs self
    ROE
    7,0 %
    -5,3 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    5,69
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-06 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate5,69
    Revenueno estimateno estimate1,1B USD
    Operating incomeno estimateno estimate234,9M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution3 analysts
    Strong buy0
    Buy2
    Hold1
    Sell0
    Strong sell0
    12-month price target$200,50 · Median $202,50
    Low $163,00High $234,00
    Operating income · consensus234,9M USD
    EPS surprise
    −9,4 %
    reported vs consensus · miss
    Revenue surprise
    −5,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$163,00
    Mean$200,50
    Median$202,50
    High$234,00
    Spot$173,57
    +15.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin20,2 %Above P75
    Net Margin14,9 %Above P75
    ROE12,3 %Above median
    Capex / Rev-4,2 %Below median
    D/E0,13Above median
    Cash Conv1,40Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 70 700 sh9 grants9 insiders
    • Backus William A.VP & Chief Accounting Officer · Stock Option → Common StockAcquired 1 800 @ $178,68grant · 2026-02-11
    • Reid Martin LutherSVP Chief Supply Chain Officer · Stock Option → Common StockAcquired 3 400 @ $178,68grant · 2026-02-11
    • Harris Theodore LDirector, Chairman, President & CEO · Stock Option → Common StockAcquired 26 900 @ $178,68grant · 2026-02-11
    • van Gunsteren Job LeonardSVP and GM, Specialty Products · Stock Option → Common StockAcquired 1 600 @ $178,68grant · 2026-02-11
    • Boned FredericSVP/GM, Human Nutri. & Health · Stock Option → Common StockAcquired 10 500 @ $178,68grant · 2026-02-11
    • Graham GeorgeSVP and Chief R&D Officer · Stock Option → Common StockAcquired 2 600 @ $178,68grant · 2026-02-11
    • Miyata HatsukiEVP, CLO, & Secretary · Stock Option → Common StockAcquired 6 300 @ $178,68grant · 2026-02-11
    • Tignor Michael BrentSVP & Chief HR Officer · Stock Option → Common StockAcquired 4 400 @ $178,68grant · 2026-02-11
    • Bengtsson Carl MartinEVP & Chief Financial Officer · Stock Option → Common StockAcquired 13 200 @ $178,68grant · 2026-02-11

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • BCPC.O Market data — financials · 2026-05-27
    • Balchem Corp Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Top holders

    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,05 %$77M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,02 %$101M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,02 %$755M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,02 %$31M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,01 %$178M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$63M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,01 %$0M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,01 %$32M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,01 %$145M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,01 %$594M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,01 %$63M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,01 %$210M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,01 %$38M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,01 %$14M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,01 %$10M
    • FMR LLCInstitutional Investor · as of 2026-03-310,01 %$101M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$19M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$29M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$12M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$19M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$15M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$11M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$6M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$3M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$3M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$1M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$3M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $015 insiders · last 365d
    • Tignor Michael BrentSVP & Chief HR Officer · Common StockOther 165 @ $177,49$29K · 2026-02-12
    • van Gunsteren Job LeonardSVP and GM, Specialty Products · Common StockOther 58 @ $177,49$10K · 2026-02-12
    • Reid Martin LutherSVP Chief Supply Chain Officer · Common StockOther 116 @ $177,49$21K · 2026-02-12
    • Harris Theodore LDirector, Chairman, President & CEO · Common StockOther 844 @ $177,49$150K · 2026-02-12
    • Backus William A.VP & Chief Accounting Officer · Common StockOther 70 @ $177,49$12K · 2026-02-12
    • Boned FredericSVP/GM, Human Nutri. & Health · Common StockOther 203 @ $177,49$36K · 2026-02-12
    • Miyata HatsukiEVP, CLO, & Secretary · Common StockOther 181 @ $177,49$32K · 2026-02-12
    • Bengtsson Carl MartinEVP & Chief Financial Officer · Common StockOther 302 @ $177,49$54K · 2026-02-12
    • Tignor Michael BrentSVP & Chief HR Officer · Common StockOther 1 200 · 2026-02-11
    • Harris Theodore LDirector, Chairman, President & CEO · Common StockOther 7 350 · 2026-02-11
    • Harris Theodore LDirector, Chairman, President & CEO · Common StockOther 18 291 · 2026-02-11
    • Harris Theodore LDirector, Chairman, President & CEO · Common StockOther 9 358 @ $178,68$1,7M · 2026-02-11
    • Reid Martin LutherSVP Chief Supply Chain Officer · Common StockOther 1 085 @ $178,68$194K · 2026-02-11
    • Graham GeorgeSVP and Chief R&D Officer · Common StockOther 700 · 2026-02-11
    • Backus William A.VP & Chief Accounting Officer · Common StockOther 490 · 2026-02-11
    • Backus William A.VP & Chief Accounting Officer · Common StockOther 1 664 · 2026-02-11
    • Backus William A.VP & Chief Accounting Officer · Common StockOther 865 @ $178,68$155K · 2026-02-11
    • Reid Martin LutherSVP Chief Supply Chain Officer · Common StockOther 2 359 · 2026-02-11
    • Boned FredericSVP/GM, Human Nutri. & Health · Common StockOther 2 870 · 2026-02-11
    • Boned FredericSVP/GM, Human Nutri. & Health · Common StockOther 2 247 · 2026-02-11
    • Boned FredericSVP/GM, Human Nutri. & Health · Common StockOther 1 151 @ $178,68$206K · 2026-02-11
    • Reid Martin LutherSVP Chief Supply Chain Officer · Common StockOther 940 · 2026-02-11
    • van Gunsteren Job LeonardSVP and GM, Specialty Products · Common StockOther 756 @ $178,68$135K · 2026-02-11
    • Tignor Michael BrentSVP & Chief HR Officer · Common StockOther 1 929 · 2026-02-11
    • Tignor Michael BrentSVP & Chief HR Officer · Common StockOther 991 @ $178,68$177K · 2026-02-11

    Short positioning

    604.5Kshares short+17.0% vs prior
    2.53days to cover
    59.6%short of daily vol
    476fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BCPC.OCanonical
    NASDAQ · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    BCPCEX21:14eEX21:1e2EX21:23eEX21:316EX21:3ecEX21:4bdEX21:6c7EX21:7d6EX21:80aEX21:9bcDiversified Sp
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 7.9%Derived (calculated)
    • Net margin (FY 2025-12-31): 14.9%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 8.8%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 10.2%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 14.4%Derived (calculated)
    • Gross margin (FY 2025-12-31): 35.7%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 7.0%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 19.0%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 20.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 9.3%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 10.2%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 20.9%Derived (calculated)
    • Return on equity (FY 2025-12-31): 12.3%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 20.9%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 50.6%Derived (calculated)
    • Return on assets (FY 2025-12-31): 9.2%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.34xDerived (calculated)
    • Current ratio (FY 2025-12-31): 2.07xDerived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 0.8%Derived (calculated)
    • Total liabilities (annual): USD 428.84MSEC XBRL filing
    • Current liabilities (annual): USD 176.38MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 5SEC XBRL filing
    • Shareholders' equity (annual): USD 1.26BSEC XBRL filing
    • Current assets (annual): USD 365.61MSEC XBRL filing
    Showing 24 of 59 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-31 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-04-30FILING10-Q filing →
    2026-04-30FILING8-K filing →
    2026-04-27FILINGDEF 14A filing →
    2026-02-20FILING10-K filing →
    2026-02-20FILING8-K filing →
    2026-02-19FILING8-K filing →
    2026-02-12 00:00 UTCINSIDER56 insider transactions — 2026-02 · net sell $4.5M 9 derivative
    2026-02-12INSIDERTignor Michael Brent transacted 165 sh — SVP & Chief HR Officer ~$29k
    2026-02-12INSIDERvan Gunsteren Job Leonard transacted 58 sh — SVP and GM, Specialty Products ~$10k
    2026-02-12INSIDERReid Martin Luther transacted 116 sh — SVP Chief Supply Chain Officer ~$21k
    2026-02-12INSIDERHarris Theodore L transacted 844 sh — Director, Chairman, President & CEO ~$150k
    2026-02-12INSIDERBackus William A. transacted 70 sh — VP & Chief Accounting Officer ~$12k
    2026-02-12INSIDERBoned Frederic transacted 203 sh — SVP/GM, Human Nutri. & Health ~$36k
    2026-02-12INSIDERMiyata Hatsuki transacted 181 sh — EVP, CLO, & Secretary ~$32k
    2026-02-12INSIDERBengtsson Carl Martin transacted 302 sh — EVP & Chief Financial Officer ~$54k
    2026-02-11INSIDERTignor Michael Brent transacted 1.2k sh — SVP & Chief HR Officer
    2026-02-11INSIDERHarris Theodore L transacted 7.3k sh — Director, Chairman, President & CEO
    2026-02-11INSIDERHarris Theodore L transacted 18.3k sh — Director, Chairman, President & CEO
    2026-02-11INSIDERHarris Theodore L transacted 9.4k sh — Director, Chairman, President & CEO ~$1.67M
    2026-02-11INSIDERReid Martin Luther transacted 1.1k sh — SVP Chief Supply Chain Officer ~$194k
    2026-02-11INSIDERGraham George transacted 700 sh — SVP and Chief R&D Officer
    2026-02-11INSIDERBackus William A. transacted 490 sh — VP & Chief Accounting Officer
    2026-02-11INSIDERBackus William A. transacted 1.7k sh — VP & Chief Accounting Officer
    2026-02-11INSIDERBackus William A. transacted 865 sh — VP & Chief Accounting Officer ~$155k
    2026-02-11INSIDERReid Martin Luther transacted 2.4k sh — SVP Chief Supply Chain Officer
    2026-02-11INSIDERBoned Frederic transacted 2.9k sh — SVP/GM, Human Nutri. & Health
    2026-02-11INSIDERBoned Frederic transacted 2.2k sh — SVP/GM, Human Nutri. & Health
    2026-02-11INSIDERBoned Frederic transacted 1.2k sh — SVP/GM, Human Nutri. & Health ~$206k
    2026-02-11INSIDERReid Martin Luther transacted 940 sh — SVP Chief Supply Chain Officer
    2026-02-11INSIDERvan Gunsteren Job Leonard transacted 756 sh — SVP and GM, Specialty Products ~$135k
    2026-02-11INSIDERTignor Michael Brent transacted 1.9k sh — SVP & Chief HR Officer
    2026-02-11INSIDERTignor Michael Brent transacted 991 sh — SVP & Chief HR Officer ~$177k
    2026-02-11INSIDERBoned Frederic acquired 10.5k sh Stock Option — SVP/GM, Human Nutri. & Health
    2026-02-11INSIDERvan Gunsteren Job Leonard acquired 1.6k sh Stock Option — SVP and GM, Specialty Products
    2026-02-11INSIDERReid Martin Luther acquired 3.4k sh Stock Option — SVP Chief Supply Chain Officer
    2026-02-11INSIDERHarris Theodore L acquired 26.9k sh Stock Option — Director, Chairman, President & CEO
    Showing the 40 most recent of 53 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage